Back to News
Market Impact: 0.22
Tevogen Regains Nasdaq Listing Compliance; Stock Up
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
Tevogen regained compliance with Nasdaq's $50 million minimum market value of listed securities requirement, according to a September 29, 2026 notice. The confirmation removes an immediate Nasdaq Global Market delisting-compliance risk, though it does not indicate an operational or financial-performance improvement.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
TVGN0.45
More News
- U.S. market regulator seeks to make it easier for funds, advisers to hold crypto
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- Nike Warns Sales Slump Will Worsen This Fiscal Year
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Nuveen CEO on Schroders Deal, Plans for Combined Company
- New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial